Viking Therapeutics liver drug succeeds in mid-stage study
Viking Therapeutics Inc said on Tuesday its experimental liver disease treatment met the main goals of a mid-stage trial by reducing cholesterol and liver fat in patients.
from Reuters: Health News https://reut.rs/2pjclm8
http://bit.ly/2zwRqiM